On Tuesday, Beyond Air Inc (NASDAQ: XAIR) was 14.71% up from the session before settling in for the closing price of $1.7. A 52-week range for XAIR has been $0.67 – $10.40.
A company in the Healthcare sector has jumped its sales by 17.29% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 73.14%. With a float of $7.54 million, this company’s outstanding shares have now reached $8.01 million.
Beyond Air Inc (XAIR) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Beyond Air Inc stocks. The insider ownership of Beyond Air Inc is 5.88%, while institutional ownership is 18.88%. The most recent insider transaction that took place on Jul 21 ’25, was worth 19,491. In this transaction CEO and Chairman of the Board of this company bought 6,000 shares at a rate of $3.25, taking the stock ownership to the 3,327,411 shares. Before that another transaction happened on Mar 14 ’25, when Company’s Director bought 1,000,000 for $0.25, making the entire transaction worth $250,050. This insider now owns 4,076,864 shares in total.
Beyond Air Inc (XAIR) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -3 earnings per share (EPS) during the time that was better than consensus figure (set at -3.2) by 0.2. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 73.14% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 74.09% during the next five years compared to 17.29% growth over the previous five years of trading.
Beyond Air Inc (NASDAQ: XAIR) Trading Performance Indicators
You can see what Beyond Air Inc (XAIR) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.73. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -7.53, a number that is poised to hit -0.68 in the next quarter and is forecasted to reach -2.07 in one year’s time.
